The design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platforms
The design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platforms
Background: elite-neutralizer-derived HIV-1 envelopes (Envs), which induce broadly neutralizing antibodies (bnAbs), can inform HIV-1 vaccine design by serving as templates for bnAb-eliciting vaccines. Since single Env-based immunizations are insufficient to induce bnAb responses, sequential regimens using multivalent immunogens or Env cocktails hold greater promise. This underscores the need to develop stable Env trimers from diverse HIV-1 strains, particularly clade-C, which accounts for 50% of global infections and over 90% in India and South Africa. While various platforms exist to stabilize soluble Env trimers for use as antigenic baits and vaccines, stabilizing clade C trimers remains challenging.
Methods: we stabilized an HIV-1 clade C trimer based on an Env isolated from a pediatric elite neutralizer (AIIMS_329) using multiple platforms, including SOSIP.v8.2, ferritin nanoparticles (NPs) and I53-50 two-component NPs, followed by characterization of their biophysical, antigenic, and immunogenic properties.
Results: the stabilized 329 Envs showed binding to multiple HIV-1 bnAbs, with negligible binding to non-neutralizing antibodies. Negative-stain electron microscopy confirmed the native-like conformation of the Envs. Multimerization of 329 SOSIP.v8.2 on ferritin and two-component I53-50 NPs improved the affinity to HIV-1 bnAbs and showed higher immunogenicity in rabbits.
Conclusions: the soluble 329 Env protein could serve as an antigenic bait, and multimeric 329 NP Envs are potential vaccine candidates.
HIV-1, neutralizing antibodies, rabbit immunization
Kumar, Sanjeev
72adbe62-7c8b-4430-aab6-6e54e94b2a91
Moral-Sánchez, Iván Del
9dd9f382-86b6-4065-bcfb-15a3e3cde271
Singh, Swarandeep
3b6a2cb8-67ab-4b93-a648-cca8394bcba8
Newby, Maddy L.
417cba47-6a6f-42b9-8b9c-640f0518c621
Allen, Joel D.
c89d5569-7659-4835-b535-c9586e956b3a
Bijl, Tom P.L.
7c64fdad-a591-419c-9d15-394a6561fd7e
Vaghani, Yog
5ba00a2d-0f90-4c85-ae24-6f1738316ef6
Jing, Liang
3af8a069-1fed-48ae-8fb9-1f992ac8872f
Lodha, Rakesh
cdfb40fa-c83b-4ec0-bfe2-33a589209a62
Ortlund, Eric A.
e2816623-430b-4a99-9413-8c1ca2e098f1
Crispin, Max
cd980957-0943-4b89-b2b2-710f01f33bc9
Patel, Anamika
21d3e101-cd43-4841-b49b-801bdb5bdd02
Sanders, Rogier W.
d3b67c2c-c725-42e7-b972-50b30be67c74
Luthra, Kalpana
40fc2436-ee10-4d8b-a414-70e7214a2bf2
22 January 2025
Kumar, Sanjeev
72adbe62-7c8b-4430-aab6-6e54e94b2a91
Moral-Sánchez, Iván Del
9dd9f382-86b6-4065-bcfb-15a3e3cde271
Singh, Swarandeep
3b6a2cb8-67ab-4b93-a648-cca8394bcba8
Newby, Maddy L.
417cba47-6a6f-42b9-8b9c-640f0518c621
Allen, Joel D.
c89d5569-7659-4835-b535-c9586e956b3a
Bijl, Tom P.L.
7c64fdad-a591-419c-9d15-394a6561fd7e
Vaghani, Yog
5ba00a2d-0f90-4c85-ae24-6f1738316ef6
Jing, Liang
3af8a069-1fed-48ae-8fb9-1f992ac8872f
Lodha, Rakesh
cdfb40fa-c83b-4ec0-bfe2-33a589209a62
Ortlund, Eric A.
e2816623-430b-4a99-9413-8c1ca2e098f1
Crispin, Max
cd980957-0943-4b89-b2b2-710f01f33bc9
Patel, Anamika
21d3e101-cd43-4841-b49b-801bdb5bdd02
Sanders, Rogier W.
d3b67c2c-c725-42e7-b972-50b30be67c74
Luthra, Kalpana
40fc2436-ee10-4d8b-a414-70e7214a2bf2
Kumar, Sanjeev, Moral-Sánchez, Iván Del, Singh, Swarandeep, Newby, Maddy L., Allen, Joel D., Bijl, Tom P.L., Vaghani, Yog, Jing, Liang, Lodha, Rakesh, Ortlund, Eric A., Crispin, Max, Patel, Anamika, Sanders, Rogier W. and Luthra, Kalpana
(2025)
The design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platforms.
Vaccines, 13 (2), [110].
(doi:10.3390/vaccines13020110).
Abstract
Background: elite-neutralizer-derived HIV-1 envelopes (Envs), which induce broadly neutralizing antibodies (bnAbs), can inform HIV-1 vaccine design by serving as templates for bnAb-eliciting vaccines. Since single Env-based immunizations are insufficient to induce bnAb responses, sequential regimens using multivalent immunogens or Env cocktails hold greater promise. This underscores the need to develop stable Env trimers from diverse HIV-1 strains, particularly clade-C, which accounts for 50% of global infections and over 90% in India and South Africa. While various platforms exist to stabilize soluble Env trimers for use as antigenic baits and vaccines, stabilizing clade C trimers remains challenging.
Methods: we stabilized an HIV-1 clade C trimer based on an Env isolated from a pediatric elite neutralizer (AIIMS_329) using multiple platforms, including SOSIP.v8.2, ferritin nanoparticles (NPs) and I53-50 two-component NPs, followed by characterization of their biophysical, antigenic, and immunogenic properties.
Results: the stabilized 329 Envs showed binding to multiple HIV-1 bnAbs, with negligible binding to non-neutralizing antibodies. Negative-stain electron microscopy confirmed the native-like conformation of the Envs. Multimerization of 329 SOSIP.v8.2 on ferritin and two-component I53-50 NPs improved the affinity to HIV-1 bnAbs and showed higher immunogenicity in rabbits.
Conclusions: the soluble 329 Env protein could serve as an antigenic bait, and multimeric 329 NP Envs are potential vaccine candidates.
Text
vaccines-13-00110-v3
- Version of Record
More information
Accepted/In Press date: 20 January 2025
Published date: 22 January 2025
Keywords:
HIV-1, neutralizing antibodies, rabbit immunization
Identifiers
Local EPrints ID: 503227
URI: http://eprints.soton.ac.uk/id/eprint/503227
ISSN: 2076-393X
PURE UUID: 2a6f7ea3-0ec0-41b9-a1cd-e2e6f1b27655
Catalogue record
Date deposited: 24 Jul 2025 16:40
Last modified: 22 Aug 2025 02:33
Export record
Altmetrics
Contributors
Author:
Sanjeev Kumar
Author:
Iván Del Moral-Sánchez
Author:
Swarandeep Singh
Author:
Maddy L. Newby
Author:
Tom P.L. Bijl
Author:
Yog Vaghani
Author:
Liang Jing
Author:
Rakesh Lodha
Author:
Eric A. Ortlund
Author:
Anamika Patel
Author:
Rogier W. Sanders
Author:
Kalpana Luthra
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics